Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex

Neuropharmacology. 2018 Sep 1:139:41-51. doi: 10.1016/j.neuropharm.2018.06.029. Epub 2018 Jun 22.

Abstract

Novel fast-acting antidepressant strategies, such as ketamine and deep brain stimulation, enhance glutamatergic neurotransmission in medial prefrontal cortex (mPFC) regions via AMPA receptor (AMPA-R) activation. We recently reported that the regionally-selective blockade of the glial glutamate transporter-1 (GLT-1) by dihydrokainic acid (DHK) microinfusion in rat infralimbic cortex (IL), the most ventral part of the mPFC, evoked immediate (10 min) antidepressant-like responses, which involved AMPA-R activation and were associated to increased serotonin (5-hydroxytryptamine, 5-HT) release. Given the reciprocal connectivity between the mPFC and the serotonergic dorsal raphe nucleus (DR), here we examined the serotoninergic mechanisms involved in the reported antidepressant-like responses of DHK microinfusion. First, we show that antidepressant-like responses evoked by IL application of DHK and citalopram are mediated by local 5-HT1A receptors (5-HT1A-R), since they are cancelled by previous IL WAY100635 microinfusion. Second, IL DHK microinfusion increases excitatory inputs onto DR, as shown by an increased glutamate and 5-HT release in DR and by a selective increase of c-Fos expression in DR 5-HT neurons, not occurring in putative GABAergic neurons. This view is also supported by an increased 5-HT release in ventral hippocampus following IL DHK microinfusion. Interestingly, antidepressant-like responses evoked by IL DHK lasted for 2 h and could be prolonged for up to 24 h by attenuating self-inhibitory effects via 5-HT1A autoreceptors. In contrast, the antidepressant-like effects of S-AMPA microinfusion in IL were short-lasting. Together, our results further support a prominent role of the IL-DR pathway and of ascending 5-HT pathways in mediating antidepressant-like responses evoked by glutamatergic mechanisms.

Keywords: Antidepressant effects; Dihydrokainic acid; Dorsal raphe; GLT-1; Infralimbic cortex; Serotonin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology*
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / metabolism*
  • Citalopram / pharmacology
  • Depressive Disorder / drug therapy
  • Depressive Disorder / metabolism
  • Dorsal Raphe Nucleus / drug effects
  • Dorsal Raphe Nucleus / metabolism
  • GABAergic Neurons / drug effects
  • GABAergic Neurons / metabolism
  • Glucose Transporter Type 1 / antagonists & inhibitors*
  • Glucose Transporter Type 1 / metabolism
  • Glutamic Acid / metabolism
  • Kainic Acid / analogs & derivatives*
  • Kainic Acid / pharmacology
  • Male
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Piperazines / pharmacology
  • Proto-Oncogene Proteins c-fos / metabolism
  • Pyridines / pharmacology
  • Random Allocation
  • Rats, Wistar
  • Receptor, Serotonin, 5-HT1A / metabolism
  • Serotonergic Neurons / drug effects
  • Serotonergic Neurons / metabolism
  • Serotonin / metabolism*
  • Serotonin Agents / pharmacology
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology

Substances

  • Antidepressive Agents
  • Glucose Transporter Type 1
  • Piperazines
  • Proto-Oncogene Proteins c-fos
  • Pyridines
  • Serotonin Agents
  • Citalopram
  • Receptor, Serotonin, 5-HT1A
  • Serotonin
  • Glutamic Acid
  • dihydrokainic acid
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
  • Kainic Acid